Details for New Drug Application (NDA): 077021
✉ Email this page to a colleague
NDA 077021 describes CILOSTAZOL, which is a drug marketed by Actavis Elizabeth, Apotex Inc, Aurobindo Pharma Usa, Chartwell Rx, Epic Pharma Llc, Hikma, Ivax Sub Teva Pharms, Nostrum Labs Inc, Pliva Hrvatska Doo, Rising, Slate Run Pharma, and Teva, and is included in fourteen NDAs. It is available from nine suppliers. Additional details are available on the CILOSTAZOL profile page.
The generic ingredient in CILOSTAZOL is cilostazol. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cilostazol profile page.
The generic ingredient in CILOSTAZOL is cilostazol. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cilostazol profile page.
Summary for 077021
| Tradename: | CILOSTAZOL |
| Applicant: | Chartwell Rx |
| Ingredient: | cilostazol |
| Patents: | 0 |
Pharmacology for NDA: 077021
| Mechanism of Action | Phosphodiesterase 3 Inhibitors |
Suppliers and Packaging for NDA: 077021
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CILOSTAZOL | cilostazol | TABLET;ORAL | 077021 | ANDA | Aphena Pharma Solutions - Tennessee, LLC | 71610-037 | 71610-037-53 | 60 TABLET in 1 BOTTLE (71610-037-53) |
| CILOSTAZOL | cilostazol | TABLET;ORAL | 077021 | ANDA | Aphena Pharma Solutions - Tennessee, LLC | 71610-037 | 71610-037-60 | 90 TABLET in 1 BOTTLE (71610-037-60) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Nov 23, 2004 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
